4//SEC Filing
ATLAS VENTURE ENTREPRENEURS FUND VI LP 4
Accession 0001209191-11-042498
CIK 0001492426other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 5:12 PM ET
Size
38.9 KB
Accession
0001209191-11-042498
Insider Transaction Report
Form 4
ATLAS VENTURE FUND VI LP
10% Owner
Transactions
- Conversion
Common Stock
2011-08-02+1,577,819→ 1,577,819 total(indirect: See FN) - Conversion
Common Stock
2011-08-02+179,740→ 1,757,559 total(indirect: See FN) - Conversion
Common Stock
2011-08-02$9.00/sh+7,086$63,774→ 2,151,679 total(indirect: See FN) - Conversion
Convertible Promissory Notes
2011-08-02→ 0 total(indirect: See FN)Exercise: $9.00→ Common Stock (7,086 underlying) - Conversion
Series A Convertible Preferred Stock
2011-08-02−1,577,819→ 0 total(indirect: See FN)→ Common Stock (1,577,819 underlying) - Conversion
Common Stock
2011-08-02$9.00/sh+387,034$3,483,306→ 2,144,593 total(indirect: See FN) - Conversion
Common Stock
2011-08-02$9.00/sh+11,834$106,506→ 2,163,513 total(indirect: See FN) - Purchase
Common Stock
2011-08-02$9.00/sh+352,576$3,173,184→ 2,516,089 total(indirect: See FN) - Purchase
Common Stock
2011-08-02$9.00/sh+6,456$58,104→ 2,522,545 total(indirect: See FN) - Purchase
Common Stock
2011-08-02$9.00/sh+10,782$97,038→ 2,533,327 total(indirect: See FN) - Conversion
Convertible Promissory Notes
2011-08-02→ 0 total(indirect: See FN)Exercise: $9.00→ Common Stock (387,034 underlying) - Conversion
Convertible Promissory Notes
2011-08-02→ 0 total(indirect: See FN)Exercise: $9.00→ Common Stock (11,834 underlying) - Conversion
Series B Convertible Preferred Stock
2011-08-02−179,740→ 0 total(indirect: See FN)→ Common Stock (179,740 underlying)
Holdings
- 2,859,851(indirect: See FN)
Common Stock
Footnotes (11)
- [F1]Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock. Every 2.374 shares of preferred stock converted into one share of common stock upon the closing of the Issuer's initial public offering.
- [F10]These securities are preferred stock of the Issuer and did not have an expiration date. Prior to the Issuer's initial public offering of common stock, the securities were convertible at any time at the election of the holder. The securities automatically converted into shares of common stock upon the closing of the issuer's initial public offering of common stock.
- [F11]Principal and accrued interest converted upon the Issuer's initial public offering of common stock, into shares of common stock.
- [F2]Includes 46,003 shares held of record by Atlas Venture Entrepreneurs' Fund VI, L.P. ("AVE"), 27,544 shares held of record by Atlas Fund VI GmbH & Co. KG ("GmbH") and 1,504,272 shares held by Atlas Venture Fund VI, L.P. ("Venture"). These shares are owned directly by AVE, GmbH and Venture. Atlas Venture Associates VI, L.P. disclaims beneficial ownership as to such shares except to the extent of its proportionate pecuniary interest therein and each of AVE, GmbH and Venture disclaim beneficial ownership to such shares other than those shares held directly by them.
- [F3]These shares are owned directly by AVE, GmbH and Venture. Atlas Venture Associates VI, L.P. disclaims beneficial ownership as to such shares except to the extent of its proportionate pecuniary interest therein and each of AVE, GmbH and Venture disclaim beneficial ownership to such shares other than those shares held directly by them.
- [F4]Includes 5,240 shares held of record by AVE, 3,137 shares held of record by GmbH and 171,363 shares held by Venture. These shares are owned directly by AVE, GmbH and Venture. Atlas Venture Associates VI, L.P. disclaims beneficial ownership as to such shares except to the extent of its proportionate pecuniary interest therein and each of AVE, GmbH and Venture disclaim beneficial ownership to such shares other than those shares held directly by them.
- [F5]Represents shares acquired upon conversion, in connection with the Issuer's initial public offering, of convertible promissory notes.
- [F6]Securities held in the name of Venture. These shares are owned directly by AVE, GmbH and Venture. Atlas Venture Associates VI, L.P. disclaims beneficial ownership as to such shares except to the extent of its proportionate pecuniary interest therein and each of AVE, GmbH and Venture disclaim beneficial ownership to such shares other than those shares held directly by them.
- [F7]Securities held in the name of GmbH. These shares are owned directly by AVE, GmbH and Venture. Atlas Venture Associates VI, L.P. disclaims beneficial ownership as to such shares except to the extent of its proportionate pecuniary interest therein and each of AVE, GmbH and Venture disclaim beneficial ownership to such shares other than those shares held directly by them.
- [F8]Securities held in the name of AVE. These shares are owned directly by AVE, GmbH and Venture. Atlas Venture Associates VI, L.P. disclaims beneficial ownership as to such shares except to the extent of its proportionate pecuniary interest therein and each of AVE, GmbH and Venture disclaim beneficial ownership to such shares other than those shares held directly by them.
- [F9]Includes 83,379 shares held of record by AVE, 49,923 shares held of record by GmbH and 2,726,549 shares held by Venture. These shares are owned directly by AVE, GmbH and Venture. Atlas Venture Associates VI, L.P. disclaims beneficial ownership as to such shares except to the extent of its proportionate pecuniary interest therein and each of AVE, GmbH and Venture disclaim beneficial ownership to such shares other than those shares held directly by them.
Documents
Issuer
HORIZON PHARMA, INC.
CIK 0001492426
Entity typeother
Related Parties
1- filerCIK 0001143182
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 5:12 PM ET
- Size
- 38.9 KB